Background and Aims: Recent meta-analysis of genome-wide association studies have identified over 241 inflammatory bowel disease susceptibility loci. However, the known variants only account for a fraction of inflammatory bowel disease heritability. To identify additional susceptibility loci, we performed a trans-ethnic meta-analysis as well as an Asian-specific meta-analysis, using all published Immunochip association results of inflammatory bowel disease. Methods: An inverse-variance fixed-effects meta-analysis was carried out across Korean and East Asian Immunochip datasets of 4156 cases and 4904 controls [Asian ancestry]. A trans-ethnic metaanalysis of inflammatory bowel disease was performed together with the European datasets of 38 155 cases and 48 485 controls genotyped on the immunochip using a Bayesian approach, MetaAnalysis of Trans-ethnic Association studies [MANTRA]. Results: We identified seven novel associations, including three novel susceptibility loci at MYO10-BASP1, PPP2R3C/KIAA0391/PSMA6/NFKB1A and LRRK1 as well as four novel secondary associations within previously known loci at NCF4, TSPAN32, CIITA and VANGL2. The new loci further implicate Abbreviations: CD, Crohn's disease; CI, confidence interval; GWAS, genome-wide association study; IBD, inflammatory bowel disease; LD, linkage disequilibrium; MAF, minor-allele frequency; OR, odds ratio; SNP, single nucleotide polymorphism; UC, ulcerative colitis alterations in B cell biology in Crohn's disease pathogenesis. The effects of five loci were universal across European and Asian ancestries, whereas the NCF4 and CIITA loci showed significant heterogeneity between European and East Asian populations. In addition, 103 previously known IBD loci showed supporting evidence of association with nominal significance [p < 0.05] in Asians. Conclusions: Our findings of new loci not previously associated with IBD support the importance of studying inflammatory bowel disease genetics in diverse populations.
Introduction
Inflammatory bowel disease [IBD] is a chronic inflammatory disorder of the gastrointestinal tract. Crohn's disease [CD] and ulcerative colitis [UC] are the two major subtypes of IBD. IBD is believed to develop due to dysregulated mucosal immune responses to gut flora in genetically susceptible individuals. 1 Although the incidence of IBD is lower in Asian populations than in Western populations, the incidence of IBD is rapidly increasing throughout Asia due to environmental changes. [2] [3] [4] [5] Epidemiological and clinical studies indicate that the phenotype and clinical course of IBD differs between Asians and Europeans. [2] [3] [4] [5] [6] [7] First, there is a male predominance of CD in Asia, with male to female ratios ranging from 1.67:1 to 2.9:1. Second, ileocolonic disease is predominant in Asian cases, comprising about two-thirds of CD cases, while colonic disease is only noted in ~10% of cases. It is unclear whether these Asian-specific clinical characteristics of IBD are solely due to the difference in the environments between Asia and the West, which underscores the necessity of genetic studies of IBD in Asian populations.
Recent large-scale studies on populations of European ancestry have markedly advanced our understanding of IBD-related genetics. A meta-analysis by the International IBD Genetics Consortium [IIBDGC] of genome-wide association studies [GWASs] and Immunochip data from 96 486 individuals with multiple ancestries [including Asian samples] identified >200 susceptibility loci for IBD, and reported an overlap in the directionality of the odds ratios [ORs] between the cohorts with European and Asian ancestry. 8 The latest genome-wide meta-analysis performed on populations with European ancestry reported 241 susceptibility loci for IBD. 9 However, it is clear that additional studies are needed to expand our understanding of the genetic architecture of IBD. Despite the differences in the clinical characteristics of IBD between different ethnicities, the number of studies in non-European populations is limited. Several GWASs on CD or UC have been performed in Asian populations. [10] [11] [12] [13] [14] [15] These studies provided insights into the genetic architecture of each disease, but not a broad view of the genetic basis of IBD in Asians. In the recent largest-to-date Asian-specific GWAS of IBD, we identified two new susceptibility loci to IBD and confirmed associations with 28 established IBD loci in Koreans. 16 In the present study, we aimed to identify [i] novel genetic variants associated with IBD in Asians through a meta-analysis of Korean and East Asian studies and [ii] additional IBD susceptibility loci through a transethnic meta-analysis of Korean, East Asian, and European studies. Here we present the findings of the meta-analyses, including seven novel associations identified at the level of genome-wide significance.
Methods

Study population
The samples of the three Immunochip datasets are described in Supplementary Table 1 . Samples in the Korean dataset were used in our previous published Immunochip studies of CD and UC, 12, 13 respectively. The summary statistics of Korean IBD data can be downloaded from a webpage [https://drive.google.com/drive/ folders/1L1Zu4G0yzVuB0Ea11HkF-XQqr9pX15-0]. Their clinical characteristics are described in Supplementary 
Quality control
The quality control [QC] procedures of the Korean, East Asian and European Immunochip datasets are described in previous publications. 8, 12, 13 As Korean Immunochip studies were performed on CD and UC separately, standard QC procedures were applied using the PLINK v1.9 software [https://www.cog-genomics.org/plink2] as described previously for the Korean IBD dataset. 12 
Statistical analysis
Association tests were performed on the Korean dataset of IBD, CD and UC using a logistic regression analysis in PLINK v1.9. A quantile-quantile [Q-Q] plot was generated using R [3.2.0] [http://www.r-project.org/] to evaluate the overall significance of the genome-wide associations and the potential impact of population stratification. The impact of population stratification was also evaluated by calculating the genomic control inflation factor [λ GC ] and the genomic inflation factor for 1000 cases and 1000 controls [λ GC1000 ] using a set of 3120 "null" SNPs that are not associated with autoimmune diseases [Supplementary [LD] with variants in previously reported loci, a conditional analysis in the regions identified in trans-ethnic meta-analysis was performed. For all variants in candidate loci that were <3 Mb away from a known locus, conditional analysis was performed on each of the three datasets separately (East Asian/European dataset, GCTA [cnsgenomics.com/ software/gcta/]; Korean dataset, PLINK v1.9) followed by a metaanalysis, or on the combined dataset. Secondary SNPs with conditional p < 5 × 10 -8 or Log 10 BF > 6 were assumed to be independent from the reported lead SNP in the region.
Asian-specific meta-analysis
For the Asian-specific meta-analyses, Korean and East Asian association results were combined using the inverse-variance method under the assumption of a fixed effect as implemented in METAL. 18 Between-study heterogeneity was quantified using the I 2 heterogeneity score, and statistical significance was assessed using the Q test statistic. For the fixed-effects model, significance was defined as p meta < 5 × 10 -8 .
Trans-ethnic meta-analysis
For the trans-ethnic meta-analyses, the three independent datasets were combined using two approaches. First, a meta-analysis was performed using the METAL software assuming fixed effects across studies and using inverse-variance weighting. Second, the ethnic-specific Immunochip summary statistics were combine using the MANTRA [Meta-Analysis of Trans-ethnic Association Studies] package, a meta-analysis software tool allowing for heterogeneity in allelic effects caused by differences in LD structure in diverse populations. 19 MANTRA results are reported as Log10 Bayes' factors [Log 10 BF]. A Log 10 BF > 6 was considered to be a genome-wide significant threshold value, and SNPs with posterior probability of heterogeneity [p het ] > 0.5 were interpreted as having significant heterogeneity. Both fixed effects results and MANTRA results are reported.
eQTL and bioinformatics analysis
To gain more insight into the potential functional roles of the novel IBD loci, a cis-eQTL analysis was performed by searching publicly available expression data generated from eQTL Blood Browser, 20 the Genotype-Tissue Expression [GTEx] database 21 and Geuvadis/1000 Genomes resources. 22 Whole blood, small intestine, transverse colon, and sigmoid colon were selected in the GTEx browser because they are the most important tissues in mucosal immunity. To explore epigenetic profiles of genomic locations associated with IBD, ENCODE histone modification data, HaploReg and Regulome DB were used to examine whether any of the SNPs or their proxies [r 2 ≥ 0.8 in the 1000 genomes of JPT + CHB reference panel] were annotated as transcription factor binding or enhancer elements. Evidence of prior association signals with autoimmune diseases or other immunerelated phenotypes was searched for in the Ensembl, UCSC Genome Bioinformatics, and GeneCards databases. When the SNP was not directly typed, a proxy SNP was used [r 2 ≥ 0.8].
Results
Asian-specific meta-analysis
To identify additional IBD risk loci in Asians, we first performed a meta-analysis using the Korean IBD Immunochip dataset and the summary statistics from the East Asian Immunochip dataset. 8, 12, 13 The combined dataset consisted of 4156 IBD cases and 4904 controls, with 1332 cases and 1185 controls from the Korean population and 2824 cases and 3719 controls from the East Asian population. Association analysis of the Korean dataset alone did not show any novel IBD loci with genome-wide significance [Supplementary Figure 3] . In a meta-analysis of the combined dataset, 12 of the previously reported regions exceeded statistical significance [p meta < 5 × 10 
Trans-ethnic meta-analysis
We performed a trans-ethnic meta-analysis of IBD using three independent Immunochip datasets. The combined dataset consisted of 42 311 IBD cases and 53 389 controls, with 1332 cases and 1185 controls from Korean population, 2824 cases and 3719 controls from East Asian population, and 38 155 cases and 48 485 controls from the European population. After applying stringent quality controls, we tested 89 051, 106 681, 126 098 and 80 291 SNPs for association in the Korean, East Asian, European and combined cohort, respectively [Supplementary Table 1] . We performed a metaanalysis using [i] inverse-variance based meta-analysis in METAL software and [ii] the MANTRA package [Supplementary Figure 5] . Following meta-analyses, the SNPs within 241 known loci 9 in the MHC region [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] hg19] and known genes were removed. 9, 23 Twenty-two loci showed significant associations with IBD in the MANTRA analyses [Log 10 BF > 6], of which 19 loci also showed significant associations in the fixed-effects trans-ethnic METAL analyses [p < 5 × 10 -8 , Supplementary Table 6 ]. As these loci were <3 Mb away from known loci except for rs2624435 near MYO10-BASP1, we performed a conditional analysis for 21 variants [Supplementary Table 7 ]. Only three loci [CIITA, TSPAN32 and NCF4] showed genome-wide significant associations following conditional analyses on the reported European lead SNPs, suggesting the presence of three novel secondary associations within previously reported loci [ Table 1 ]. The MANTRA analyses of CD showed eight loci with Log 10 BF > 6 [Supplementary 
Novel loci
All three newly discovered SNPs are non-coding variants, rs2624435 in MYO10-BASP1 at 5p15 for IBD, rs57275892 in PPP2R3C/ KIAA0391/PSMA6/NFKB1A at 14q13, and rs7170683 in LRRK1 at 15q26 for CD. The SNP densities across the MYO10-BASP1 and LRRK1 loci were sparse [ Figure 1A , 1B]; however, upon examining the eQTL database, rs2624435 showed an association with BASP1 expression levels in blood, and rs7170683 showed an association with both LRRK1 and ALDH1A3 expression levels in lymphoblastoid cell lines of European ancestry [Supplementary and BASP1. The biological function of the Brain Acid Soluble Protein 1 [BASP1] gene is not well known, except for its involvement in nephrogenesis as a transcriptional co-suppressor, 24 whereas an unconventional myosin, Myosin X [MYO10], is implicated in phagocytosis via its role in filopodia induction. Macrophages lacking Myo10 showed markedly reduced filopodia formation. 25 A novel CD susceptibility locus at rs7170683 is located in the Leucine-rich repeat kinase 1 [LRRK1]. LRRK1 belongs to a member of the ROCO family of proteins with multiple functional domains including ankyrin-like repeats, leucine-rich repeats [LRRs], a Ras-like GTPase domain [ROC] and an adjacent C-terminal domain [COR] , and a serine-threonine kinase domain. Its homolog LRRK2 was shown to be associated with CD 23 and Parkinson's disease. 26 LRRK1 is involved in a variety of functions including autophagy and osteoclast differentiation. A recent knock-out mice study reported that LRRK1 plays a critical role in B cell development and antibody production by regulating NF-kB signaling. 27 The other novel CD susceptibility SNP [rs57275892] at 14q13 is located ~500 bp upstream of PSMA6 [ Figure 1C Table 8 ]. PPP2R3C is a regulatory subunit of a serine/threonine phosphatase, protein phosphatase 2. Knock-out and transgenic mice studies show that PPP2R3C is involved in both the survival of germinal center B cells and the differentiation of peritoneal B cells into autoantibody-producing plasma cells, suggesting possible roles in inflammatory diseases. Table 1 , Supplementary  Figure 6 ]. rs2074023 is located ~452 kb away from the previously reported rs907611 8, 9 [r 2 < 0.2]; however, conditional logistic regression analysis on rs907611 supported the independent effects of the two SNPs [Supplementary Table 7] . Examination of the eQTL database for rs2074023 showed that it is associated with the expression levels of both C11orf21 and TSPAN32 in lymphoblastoid cell lines and small intestine, whereas previously reported rs907611 is associated with the expression levels of CTSD in blood [Supplementary Table 8 ], supporting their independent effects. A search of HaploReg v4 for rs2074023 showed a Regulome DB score 1b, indicating that it is likely to affect binding and to be linked to expression of a gene target [Supplementary Table 9 ]. TSPAN32 is a member of the tetraspanins of integral membrane proteins with functional roles in cell motility, membrane fusion, proliferation and immunity. Tetraspanins, of which over 30 have been identified in humans, can associate with one another and with other molecules such as integrins or proteins of the immunoglobulin superfamily to form a network on the surfaces of many different cell types. 29 Knock-out mice experiments have shown that TSPAN32 may play a role in the negative regulation of peripheral T-lymphocyte proliferation, 30 suggesting that it may have roles in inflammatory diseases. The biological function of the other gene, C11orf21, is unknown; however, rs7944004, located in 5.7 kb 3' of C11orf21 [14.4 kb away from rs2074023 with r 2 = 0.75], is associated with chronic lymphocytic leukemia. 31 The association signal [rs17371986] at chromosome 1q23 is located at 3.8 kb from the 3' end of VANGL planar cell polarity protein 2 gene [VANGL2] in a LD region of 110.7 kb that includes NCSTN, NHLH1 and VANGL2 [ Table 1 , Supplementary  Figure 6 ]. The previously reported rs4656958 [~2 kb 5' of ITLN1] is located ~454 kb away from rs17371986 [r 2 < 0.2]; however, conditional logistic regression analysis of rs4656958 supported the independent effects of the two SNPs [Supplementary Table 7] . Examination of the eQTL database for rs17371986 showed that it is associated with VANGL2 expression levels in the sigmoid colon in the GTEx database [Supplementary Table 8 ]. As VANGL2 is involved in the regulation of planar cell polarity, its involvement in UC susceptibility is not obvious.
Loci showing heterogeneity between Asian and European populations
Of the two novel IBD associations that showed significant heterogeneity between Asian and European populations, association effects of NCF4 were mapped to two independent SNPs in two populations [p het = 1.0, Supplementary limitation of using only 80 291 common SNPs for the analyses, we identified seven novel associations, including three novel susceptibility loci at MYO10-BASP1 for IBD, PPP2R3C/KIAA0391/PSMA6/ NFKB1A and LRRK1 for CD, and four novel secondary associations within previously known loci at NCF4, TSPAN32, CIITA and VANGL2. In addition, we were able to replicate 103 loci of known IBD susceptibility loci in Asian samples [Supplementary Table 5 ]. The comparison of the effect sizes for all 193 SNPs from known loci and seven novel associations identified in the present study between Asians and Europeans revealed a positive correlation in the direction of effects for both CD and UC [ Figure 2 ] [r 2 = 0.40 and p = 1.54 × 10 -23 for CD; r 2 = 0.57 and p = 1.84 × 10 -37 for UC]. This observation is consistent with a previous large-scale study that reported substantial genetic overlap between Europeans and Asians. 8 Of the two novel IBD associations showing significant heterogeneity between Asian and European populations, the association effects of NCF4 were mapped to two independent SNPs in two populations. The fact that the risk alleles for both SNPs were associated with decreased expression of NCF4 in blood eQTL database suggests that the heterogeneity of the most significant signals might be due to the LD difference between Asians and Europeans [Supplementary Figure 7] . The NCF4-CSF2RB region showed genome-wide significant associations with both IBD and CD in Asians, but with CD only in Europeans. Previous studies have shown association of rs4821544 with ileal CD in Europeans [37] [38] [39] and its effects on reactive oxygen species production following stimulation with GM-CSF. 40 Stronger association of NCF4 in Asians could be due to the fact that ileocolonic disease is the most common type of CD in Asian populations, whereas ileal, colonic and ileocolonic disease occur in equal proportions in the CD of western populations.
In this study, we conducted the largest Immunochip trans-ethnic meta-analysis of IBD and discovered seven novel associations, including three novel susceptibility loci and four novel independent associations within previously known loci. The new loci suggest that additional factors are involved in the T cell biology and B cell immunity of IBD. In conclusion, this trans-ethnic study advances our understanding of the genetic architecture of IBD susceptibility by discovering novel associations and revealing allelic heterogeneity between Asian and European populations.
